RPCONE
TEVA icon

Retirement Planning Company of New England’s Teva Pharmaceuticals TEVA Stock Holding History

Retirement Planning Company of New England’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$993K Sell
29,312
-2,330
-7% -$77.6K 0.36% 77
2026
Q1 		$953K Buy
31,642
+10
+0% +$322 0.39% 76
2025
Q4 		$987K Sell
31,632
-1,598
-5% -$39.4K 0.4% 70
2025
Q3 		$671K Buy
33,230
+588
+2% +$10.3K 0.27% 105
2025
Q2 		$547K Buy
32,642
+1,414
+5% +$22.8K 0.24% 120
2025
Q1 		$480K Buy
31,228
+15,393
+97% +$275K 0.24% 125
2024
Q4 		$349K Sell
15,835
-700
-4% -$12.7K 0.17% 154
2024
Q3 		$298K Buy
16,535
+59
+0.4% +$1.03K 0.15% 168
2024
Q2 		$268K Sell
16,476
-202
-1% -$3.11K 0.15% 172
2024
Q1 		$235K Sell
16,678
-55
-0.3% -$693 0.13% 193
2023
Q4 		$175K Buy
16,733
+449
+3% +$4.19K 0.08% 223
2023
Q3 		$166K Sell
16,284
-2,458
-13% -$22.9K 0.09% 195
2023
Q2 		$141K Buy
18,742
+182
+1% +$1.48K 0.08% 217
2023
Q1 		$164K Sell
18,560
-673
-3% -$6.65K 0.1% 211
2022
Q4 		$175K Sell
19,233
-827
-4% -$7.22K 0.11% 200
2022
Q3 		$161K Sell
20,060
-249
-1% -$2.2K 0.12% 194
2022
Q2 		$152K Buy
20,309
+855
+4% +$7.45K 0.1% 204
2022
Q1 		$182K Buy
19,454
+992
+5% +$8.28K 0.1% 221
2021
Q4 		$147K Buy
+18,462
New +$167K 0.07% 257

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Retirement Planning Company of New England's TEVA Position: Q2 2026 in Review

Retirement Planning Company of New England reduced its Teva Pharmaceuticals (TEVA) stake by 7.4% in Q2 2026, selling an estimated $77.6K and leaving 29,312 shares worth $993K. The position accounts for 0.36% of the portfolio, ranked #77.

Retirement Planning Company of New England first reported a position in TEVA in Q4 2021 and has held it in 19 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Retirement Planning Company of New England held 29,312 shares of Teva Pharmaceuticals worth $993K as of Q2 2026.
  • Retirement Planning Company of New England sold 2,330 Teva Pharmaceuticals shares in Q2 2026, an estimated $77.6K.
  • Teva Pharmaceuticals made up 0.36% of Retirement Planning Company of New England's portfolio in Q2 2026, its #77 holding.
  • Retirement Planning Company of New England first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Retirement Planning Company of New England's 13F filing for Q2 2026, filed 30 Jul 2026.